Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11802157 Methods and compositions for modulating CAR-T activity

Patent 11802157 was granted and assigned to Sana Biotechnology on October, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Sana Biotechnology
Sana Biotechnology
Date Filed
February 7, 2022
Date of Patent
October 31, 2023
Patent Applicant
Sana Biotechnology
Sana Biotechnology
Patent Application Number
17666523
Patent Citations
‌
US Patent 7982011 Mutated anti-cd22 antibodies and immunoconjugates
‌
US Patent 11026975 Chimeric antigen receptor (CAR) binding to BCMA, and uses thereof
‌
US Patent 8906682 Methods for treatment of cancer
‌
US Patent 7253273 Treatment of neuropathic pain with zinc finger proteins
‌
US Patent 7262054 Zinc finger proteins for DNA binding and gene regulation in plants
‌
US Patent 7355012 Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells
‌
US Patent 7361635 Simultaneous modulation of multiple genes
‌
US Patent 7541034 Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors
Patent Citations Received
‌
US Patent 11987628 Methods and compositions for modulating CAR-T activity
0
Patent Inventor Names
Sonja Schrepfer
Lindong Weng
Terry J. Fry
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11802157
Patent Primary Examiner
‌
Michael D Burkhart

Find more entities like US Patent 11802157 Methods and compositions for modulating CAR-T activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo